Pfizer Debt Current vs Shareholders Equity Analysis

PFE
 Stock
  

USD 50.11  0.25  0.50%   

Pfizer financial indicator trend analysis is much more than just breaking down Pfizer Inc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pfizer Inc is a good investment. Please check the relationship between Pfizer Debt Current and its Shareholders Equity accounts. Please check Your Equity Center.

Debt Current vs Shareholders Equity

Debt Current vs Shareholders Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pfizer Inc Debt Current account and Shareholders Equity. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Pfizer's Debt Current and Shareholders Equity is -0.24. Overlapping area represents the amount of variation of Debt Current that can explain the historical movement of Shareholders Equity in the same time period over historical financial statements of Pfizer Inc, assuming nothing else is changed. The correlation between historical values of Pfizer's Debt Current and Shareholders Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Debt Current of Pfizer Inc are associated (or correlated) with its Shareholders Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Shareholders Equity has no effect on the direction of Debt Current i.e., Pfizer's Debt Current and Shareholders Equity go up and down completely randomly.

Correlation Coefficient

-0.24
Relationship DirectionNegative 
Relationship StrengthInsignificant

Debt Current

The current portion of Total Debt; reported if the company operates a classified balance sheet that segments current and non-current liabilities.

Shareholders Equity

A principal component of the balance sheet; in addition to Total Liabilities and Total Assets; that represents the total of all stockholders' equity (deficit) items; net of receivables from officers; directors; owners; and affiliates of the entity which are attributable to the parent.
Most indicators from Pfizer fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pfizer Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please check Your Equity Center.Pfizer Issuance Repayment of Debt Securities is projected to based on the last few years of reporting. The past year's Issuance Repayment of Debt Securities was at 7.89 Billion. The current year Net Cash Flow Investment Acquisitions and Disposals is expected to grow to about 11.5 B, whereas Net Cash Flow Business Acquisitions and Disposals is forecasted to decline to (13.5 B).
 2019 2021 2022 (projected)
Consolidated Income16.3 B18.75 B17.02 B
Direct Expenses10.22 B30.82 B33.25 B

Pfizer fundamental ratios Correlations

0.360.660.24-0.090.48-0.280.810.580.490.170.340.61-0.59-0.730.130.240.76-0.350.650.410.170.21-0.46
0.360.060.90.730.310.330.16-0.20.470.910.170.360.190.140.030.50.130.33-0.070.610.820.80.25
0.660.060.11-0.050.04-0.160.720.660.06-0.040.180.13-0.8-0.76-0.20.280.83-0.540.78-0.1-0.31-0.23-0.57
0.240.90.110.730.20.320.18-0.070.240.880.140.220.150.09-0.030.740.210.280.030.440.60.590.29
-0.090.73-0.050.73-0.320.4-0.1-0.32-0.020.85-0.36-0.080.440.44-0.030.25-0.080.12-0.260.160.430.430.21
0.480.310.040.2-0.32-0.20.30.010.780.110.840.79-0.14-0.170.110.240.080.520.250.780.560.40.32
-0.280.33-0.160.320.4-0.2-0.41-0.31-0.330.32-0.21-0.390.290.260.080.17-0.210.26-0.66-0.150.210.170.27
0.810.160.720.18-0.10.3-0.410.870.340.080.090.43-0.5-0.830.360.250.76-0.540.740.11-0.15-0.15-0.59
0.58-0.20.66-0.07-0.320.01-0.310.87-0.1-0.24-0.130.07-0.56-0.920.370.190.72-0.730.64-0.31-0.55-0.5-0.69
0.490.470.060.24-0.020.78-0.330.34-0.10.320.620.86-0.05-0.030.020.020.020.350.290.870.70.560.1
0.170.91-0.040.880.850.110.320.08-0.240.32-0.030.220.380.30.080.34-0.030.22-0.160.460.690.650.21
0.340.170.180.14-0.360.84-0.210.09-0.130.62-0.030.63-0.41-0.12-0.430.310.080.550.390.680.440.360.38
0.610.360.130.22-0.080.79-0.390.430.070.860.220.63-0.15-0.160.030.120.180.290.430.880.530.330.18
-0.590.19-0.80.150.44-0.140.29-0.5-0.56-0.050.38-0.41-0.150.790.46-0.24-0.680.42-0.80.050.320.170.47
-0.730.14-0.760.090.44-0.170.26-0.83-0.92-0.030.3-0.12-0.160.79-0.16-0.24-0.780.63-0.710.160.40.30.67
0.130.03-0.2-0.03-0.030.110.080.360.370.020.08-0.430.030.46-0.16-0.170.02-0.2-0.3-0.12-0.07-0.17-0.2
0.240.50.280.740.250.240.170.250.190.020.340.310.12-0.24-0.24-0.170.460.250.290.230.220.240.29
0.760.130.830.21-0.080.08-0.210.760.720.02-0.030.080.18-0.68-0.780.020.46-0.550.69-0.06-0.27-0.18-0.53
-0.350.33-0.540.280.120.520.26-0.54-0.730.350.220.550.290.420.63-0.20.25-0.55-0.410.60.680.520.93
0.65-0.070.780.03-0.260.25-0.660.740.640.29-0.160.390.43-0.8-0.71-0.30.290.69-0.410.15-0.24-0.19-0.43
0.410.61-0.10.440.160.78-0.150.11-0.310.870.460.680.880.050.16-0.120.23-0.060.60.150.840.680.45
0.170.82-0.310.60.430.560.21-0.15-0.550.70.690.440.530.320.4-0.070.22-0.270.68-0.240.840.930.51
0.210.8-0.230.590.430.40.17-0.15-0.50.560.650.360.330.170.3-0.170.24-0.180.52-0.190.680.930.33
-0.460.25-0.570.290.210.320.27-0.59-0.690.10.210.380.180.470.67-0.20.29-0.530.93-0.430.450.510.33
Click cells to compare fundamentals

Pfizer Account Relationship Matchups

Pfizer fundamental ratios Accounts

201720182019202020212022 (projected)
Inventories7.58 B7.51 B8.28 B8.05 B9.06 B7.92 B
Receivables8.22 B8.03 B8.72 B7.93 B11.48 B11.8 B
Accounts Payable4.66 B4.67 B4.22 B4.31 B5.58 B4.7 B
Accumulated Other Comprehensive Income(11.04 B)(9.32 B)(11.28 B)(11.64 B)(10.48 B)(11.3 B)
Total Assets171.8 B159.42 B167.49 B154.23 B181.48 B196.04 B
Current Assets41.14 B49.93 B32.8 B35.07 B59.69 B60.12 B
Assets Non Current132.67 B130.66 B109.5 B134.69 B121.22 B117.09 B
Cash and Equivalents1.34 B1.14 B1.3 B1.78 B1.94 B2.71 B
Cash and Equivalents USD2.6 B1.34 B1.14 B1.3 B1.17 B1.21 B
Total Debt42.09 B43.49 B41.74 B52.15 B59.97 B55.81 B
Debt Current10.69 B9.95 B8.83 B16.2 B18.62 B20.09 B
Debt Non Current31.4 B33.54 B32.91 B35.95 B32.36 B31.27 B
Total Debt USD42.09 B43.49 B41.74 B52.15 B59.97 B55.81 B
Shareholders Equity71.31 B63.41 B63.14 B63.24 B77.2 B82.19 B
Shareholders Equity USD59.54 B71.31 B63.41 B63.14 B56.83 B60.95 B
Goodwill and Intangible Assets107.1 B104.69 B88.62 B94.02 B84.62 B84.29 B
Inventory6.78 B7.58 B7.51 B8.28 B7.45 B7.1 B
Investments22.37 B25.66 B20.46 B28.67 B25.8 B27.9 B
Investments Current15.26 B18.65 B17.69 B8.53 B7.67 B7.87 B
Investments Non Current7.12 B7.01 B2.77 B20.15 B18.13 B14.66 B
Total Liabilities100.49 B96.02 B104.34 B90.99 B104.28 B113.85 B
Current Liabilities30.43 B31.86 B37.3 B25.92 B42.67 B35.05 B
Liabilities Non Current80.66 B69.71 B63.81 B66.74 B60.06 B62.82 B
Trade and Non Trade Payables4.54 B4.66 B4.67 B4.22 B4.85 B4.82 B
Property Plant and Equipment Net13.32 B13.87 B13.38 B13.97 B12.57 B12.86 B
Trade and Non Trade Receivables8.22 B8.22 B8.03 B8.72 B7.85 B8.38 B
Accumulated Retained Earnings Deficit71.77 B85.29 B89.55 B97.67 B112.32 B98.16 B
Tax Assets4.85 B4.91 B5.3 B5.44 B4.9 B5.79 B
Tax Liabilities35.19 B23.07 B19.7 B18.68 B16.82 B20.51 B

Pfizer Investors Sentiment

The influence of Pfizer's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Pfizer. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Pfizer's public news can be used to forecast risks associated with investment in Pfizer. The trend in average sentiment can be used to explain how an investor holding Pfizer can time the market purely based on public headlines and social activities around Pfizer Inc. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Pfizer's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pfizer's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Pfizer's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Pfizer.

Pfizer Implied Volatility

    
  29.44  
Pfizer's implied volatility exposes the market's sentiment of Pfizer Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pfizer's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pfizer stock will not fluctuate a lot when Pfizer's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pfizer in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pfizer's short interest history, or implied volatility extrapolated from Pfizer options trading.

Currently Active Assets on Macroaxis

Please check Your Equity Center. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.77
Market Capitalization
278.3 B
Quarterly Revenue Growth YOY
0.47
Return On Assets
0.13
Return On Equity
0.37
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.